Oncology

Your Article Summary

See Latest Articles

Gastric cancer
The Lancet - Early Online Publication, 07/23/09

Hartgrink HH et al. - In a review of gastric cancer, this article presents an update of the incidence, causes, pathology, and treatment of gastric cancer, consisting of surgery, new strategies with neoadjuvant and adjuvant chemotherapy or radiotherapy, or both, novel treatment strategies using gene signatures, and the effect of caseload on pt outcomes.

• Gastric cancer is the second most frequent cause of cancer death worldwide, although much geographical variation in incidence exists.
• Prevention and personalised treatment are the best options to reduce gastric cancer mortality rates.
• Prevention strategies should be based on specific risk profiles, including Helicobacter pylori genotype, host gene polymorphisms, presence of precursor lesions, and environmental factors.

• Although adequate surgery remains the cornerstone of gastric cancer treatment, this single modality seems to have reached its maximum achievable effect for local control and survival.
• Minimally invasive techniques can be used for treatment of early gastric cancers.
• Achievement of locoregional control for advanced disease remains very difficult.
• Extended resections that are standard practice in some Asian countries have not been shown to be as effective in other developed countries.

Related Articles

See all related articles

CHD5 is down-regulated through promoter hypermethylation in gastric cancer
BMC: Journal of Biomedical Science, 10/26/09    Relevance Score: 71%

Promoter hypermethylation mediates downregulation of thiamine receptor slc19a3 in gastric cancer
Tumor Biology, 10/12/09    Relevance Score: 71%

KAP1 Is Associated With Peritoneal Carcinomatosis in Gastric Cancer
Annals of Surgical Oncology, 11/11/09    Relevance Score: 69%

Management of patients with pregnancy-associated gastric cancer in Japan: a mini-review
International Journal of Clinical Oncology, 10/30/09    Relevance Score: 69%

A Study of Oxidative Stress Parameters in Anti-Helicobacter Pylorus Immunoglobulin G Positive and Negative Gastric Cancer Patients
Yonsei Medical Journal, 10/29/09    Relevance Score: 69%

Today in GI Oncology...keeping you current

Receive free subspecialty "5-minute updates" via email

Loss of imprinting of the insulin-like growth factor II (IGF2) gene in esophageal normal and adenocarcinoma tissues
Carcinogenesis, 12/15/09

Interleukin-18 increases metastasis and immune escape of stomach cancer via the downregulation of CD70 and maintenance of CD44
Carcinogenesis, 12/15/09

Toxicity against gastric cancer cells by combined treatment with 5-fluorouracil and mitomycin c: Implication in oxidative stress
Cancer Chemotherapy and Pharmacology, 12/15/09

 See all of GI Oncology